当前位置: 首页 > 详情页

Multimorbidity and Genetic Characteristics of DICER1 Syndrome Based on Systematic Review

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Key Lab Pediat Hematol Oncol, Natl Key Discipline Pediat, Minist Educ,Hematol Oncol Ctr, Beijing, Peoples R China; [3]Capital Med Univ, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China; [4]Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Beijing, Peoples R China; [5]10 Xitoutiao, Beijing 100069, Peoples R China
出处:
ISSN:

关键词: DICER1 multimorbidity gene mutation clinical characteristics

摘要:
It has been reported that germline DICER1 mutations correlate with a distinctive human disease syndrome. Many published studies within this field have been conducted based on rare cases. We systematically searched bibliographic databases, including PubMed, Embase, and COSMIC for articles which are related to diseases covered by DICER1 syndrome. The weighted summary of mutation frequencies among patients with pleuropulmonary blastoma (PPB), cystic nephroma (CN), and Sertoli-Leydig cell tumor (SLCT) were calculated. Forty-nine eligible articles were included. In total, 72 cases with multimorbidity of DICER1 syndrome were identified. More females (n = 46, 64%) presented with multimorbidity than males (n = 18, 25%) and the remaining 8 patients' sex were unknown. Nineteen of 72 patients with multimorbidity suffered from another disease that was not yet included in DICER1 syndrome, which would provide potential phenotypes of DICER1 syndrome. The germline DICER1 mutation frequencies in PPB, CN, and SLCT were 66.9%, 73.2%, and 57.1%, respectively. The somatic DICER1 mutation frequencies of PPB, CN, and SLCT were 92.4%, 87.9%, and 43.3%, respectively. Majority of patients with multimorbidity of DICER1 syndrome were mutation positive individuals so that multimorbidity may suggest the possible germline mutation of these patients and their relatives.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 血液学 4 区 肿瘤学 4 区 儿科
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 血液学 4 区 肿瘤学 4 区 儿科
JCR分区:
出版当年[2015]版:
Q3 PEDIATRICS Q4 ONCOLOGY Q4 HEMATOLOGY
最新[2023]版:
Q3 PEDIATRICS Q4 HEMATOLOGY Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [3]Capital Med Univ, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China; [5]10 Xitoutiao, Beijing 100069, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院